These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
24 related articles for article (PubMed ID: 10596455)
1. Effect of sex and genotype of the host on the anthelmintic efficacy of albendazole microcrystals, in the CBi-IGE Codina AV; Priotti J; Leonardi D; Vasconi MD; Lamas MC; Hinrichsen LI Parasitology; 2021 Nov; 148(13):1545-1553. PubMed ID: 35060467 [TBL] [Abstract][Full Text] [Related]
2. Appraisal of Chitosan-Coated Lipid Nano-Combination with Miltefosine and Albendazole in the Treatment of Murine Trichinellosis: Experimental Study with Evaluation of Immunological and Immunohistochemical Parameters. Ibrahim AF; Selim SM; Shafey DA; Sweed DM; Farag SA; Gouda MA Acta Parasitol; 2024 Mar; 69(1):929-950. PubMed ID: 38489009 [TBL] [Abstract][Full Text] [Related]
3. Albendazole metabolites excretion in human saliva as a biomarker to assess treatment compliance in mass drug administration (MDA) anthelmintic programs. Nieves E; Cimino R; Krolewiecki A; Juarez M; Lanusse C; Alvarez L; Ceballos L Sci Rep; 2024 Mar; 14(1):6271. PubMed ID: 38491091 [TBL] [Abstract][Full Text] [Related]
4. The neuroprotective potential of curcumin on T. Spiralis infected mice. Abdeltawab MS; Abdel-Shafi IR; Aboulhoda BE; Mahfoz AM; Hamed AM BMC Complement Med Ther; 2024 Feb; 24(1):99. PubMed ID: 38388410 [TBL] [Abstract][Full Text] [Related]
9. Enhanced bioavailability and anthelmintic efficacy of mebendazole in redispersible microparticles with low-substituted hydroxypropylcellulose. de la Torre-Iglesias PM; García-Rodriguez JJ; Torrado G; Torrado S; Torrado-Santiago S; Bolás-Fernández F Drug Des Devel Ther; 2014; 8():1467-79. PubMed ID: 25258515 [TBL] [Abstract][Full Text] [Related]
11. Efficacy of flubendazole and albendazole against Trichinella spiralis in mice. Chung MS; Joo KH; Quan FS; Kwon HS; Cho SW Parasite; 2001 Jun; 8(2 Suppl):S195-8. PubMed ID: 11484354 [TBL] [Abstract][Full Text] [Related]
12. Methimazole-mediated enhancement of albendazole oral bioavailability and anthelmintic effects against parenteral stages of Trichinella spiralis in mice: the influence of the dose-regime. López-García ML; Torrado S; Torrado S; Martínez AR; Bolás F Vet Parasitol; 1998 Feb; 75(2-3):209-19. PubMed ID: 9637222 [TBL] [Abstract][Full Text] [Related]
13. Improving bioavailability and anthelmintic activity of albendazole by preparing albendazole-cyclodextrin complexes. García-Rodriguez JJ; Torrado J; Bolás F Parasite; 2001 Jun; 8(2 Suppl):S188-90. PubMed ID: 11484352 [TBL] [Abstract][Full Text] [Related]
14. Evaluation of albendazole prodrugs in experimental trichinellosis. Yépez-Mulia L; Morales-Hurtado R; Viveros-Guzmán N; Cedillo-Rivera R; Hernández-Luis F; Castillo R; Hernández-Campos A; Muñoz O Arch Med Res; 1999; 30(5):368-74. PubMed ID: 10596455 [TBL] [Abstract][Full Text] [Related]
15. Albendazole versus ricobendazole (albendazole-sulphoxide) against enteral and parenteral stages of Trichinella spiralis in mice. Lopez-Garcia ML; Torrado-Duran S; Torrado-Duran J; Martínez-Fernández AR; Bolás-Fernández F Int J Parasitol; 1997 Jul; 27(7):781-5. PubMed ID: 9279580 [TBL] [Abstract][Full Text] [Related]
16. Bioavailability and efficacy characteristics of two different oral liquid formulations of albendazole. García JJ; Bolás F; Torrado JJ Int J Pharm; 2003 Jan; 250(2):351-8. PubMed ID: 12527162 [TBL] [Abstract][Full Text] [Related]